Predicting post-treatment survival in cancer patients with microRNAs
US7745134B2 · kind B2 · utility
2Cited by
0References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 9, 2008 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Apr 9, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/178
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention provides a method for predicting the post-treatment survival prospect of a cancer patient based on the expression level(s) of microRNAs hsa-miR137, hsa-miR372, hsa-miR182*, hsa-miR221, and hsa-let-7a in that cancer patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.